Rapid antibiotic susceptibility testing of bacteria from patients’ blood via assaying bacterial metabolic response with surface-enhanced Raman spectroscopy

Yin-Yi Han,Yi-Chun Lin,Wei-Chih Cheng,Yu-Tzu Lin,Lee-Jene Teng,Juen-Kai Wang,Yuh-Lin Wang
DOI: https://doi.org/10.1038/s41598-020-68855-w
IF: 4.6
2020-07-27
Scientific Reports
Abstract:Abstract Blood stream infection is one of the major public health issues characterized with high cost and high mortality. Timely effective antibiotics usage to control infection is crucial for patients’ survival. The standard microbiological diagnosis of infection however can last days. The delay in accurate antibiotic therapy would lead to not only poor clinical outcomes, but also to a rise in antibiotic resistance due to widespread use of empirical broad-spectrum antibiotics. An important measure to tackle this problem is fast determination of bacterial antibiotic susceptibility to optimize antibiotic treatment. We show that a protocol based on surface-enhanced Raman spectroscopy can obtain consistent antibiotic susceptibility test results from clinical blood-culture samples within four hours. The characteristic spectral signatures of the obtained spectra of Staphylococcus aureus and Escherichia coli —prototypic Gram-positive and Gram-negative bacteria—became prominent after an effective pretreatment procedure removed strong interferences from blood constituents. Using them as the biomarkers of bacterial metabolic responses to antibiotics, the protocol reported the susceptibility profiles of tested drugs against these two bacteria acquired from patients’ blood with high specificity, sensitivity and speed.
multidisciplinary sciences
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to quickly determine the antibiotic sensitivity of bacteria in clinical blood samples. Bloodstream infection (BSI) is a major public health problem, characterized by high cost and high mortality. Timely and effective use of antibiotics is crucial for controlling infection and improving patient survival rates. However, standard microbiological diagnostic methods may take several days, which can lead to a delay in antibiotic treatment. This may not only result in poor clinical outcomes but also promote the rise of antibiotic resistance due to the widespread use of empirical broad - spectrum antibiotics. To this end, the researchers proposed a method based on surface - enhanced Raman spectroscopy (SERS) that can obtain consistent antibiotic sensitivity test results from clinical blood culture samples within four hours. After effectively removing the strong interference of blood components through a pre - treatment procedure, the characteristic spectral signals of Staphylococcus aureus and Escherichia coli - as typical Gram - positive and Gram - negative bacteria - become obvious. These signals are used as biomarkers of the bacterial metabolism in response to antibiotics to report the sensitivity profiles of the test drugs to these two bacteria with high specificity, sensitivity and speed. This method aims to optimize antibiotic treatment regimens, reduce the occurrence of antibiotic resistance, and improve the treatment outcomes of patients with bloodstream infections. In this way, the researchers hope to develop a faster and more reliable method to determine the antibiotic sensitivity of bacteria, thereby improving the clinical outcomes of patients.